Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"

Name: Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"
Creator: Seiko Sugiyama
Published: 2020-12-10T10:10:44.611Z
Keywords: Biomarkers, Autoimmune Disorder, Retrospective Study, Immune Response, Adverse Effect of Drug, Bullous Disease

Sugiyama, Seiko; Yamamoto, Takenobu; Aoyama, Yumi

doi:10.17632/cpnzrbvsyk.1

Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"

Published: 10-12-2020| Version 1 | DOI: 10.17632/cpnzrbvsyk.1

Contributors:

Seiko Sugiyama,

Takenobu Yamamoto,

Yumi Aoyama

Description

Contents: Supplemental Methods and Legends Supplemental Fig 1 Supplemental Fig 2 Supplemental Fig 3 Supplemental Fig 4

Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"

Description

Files